Logo image of HLBN.DE

HOLCIM LTD (HLBN.DE) Stock Fundamental Analysis

FRA:HLBN - Deutsche Boerse Ag - CH0012214059 - Common Stock - Currency: EUR

99.28  -0.87 (-0.87%)

Fundamental Rating

5

HLBN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 13 industry peers in the Construction Materials industry. HLBN has an excellent profitability rating, but there are some minor concerns on its financial health. HLBN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year HLBN was profitable.
HLBN had a positive operating cash flow in the past year.
HLBN had positive earnings in each of the past 5 years.
In the past 5 years HLBN always reported a positive cash flow from operatings.
HLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFHLBN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

The Return On Assets of HLBN (5.38%) is better than 76.92% of its industry peers.
With a decent Return On Equity value of 10.73%, HLBN is doing good in the industry, outperforming 76.92% of the companies in the same industry.
HLBN has a Return On Invested Capital of 7.46%. This is in the better half of the industry: HLBN outperforms 76.92% of its industry peers.
HLBN had an Average Return On Invested Capital over the past 3 years of 6.46%. This is in line with the industry average of 7.75%.
The 3 year average ROIC (6.46%) for HLBN is below the current ROIC(7.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.38%
ROE 10.73%
ROIC 7.46%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
HLBN.DE Yearly ROA, ROE, ROICHLBN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

HLBN has a Profit Margin of 11.07%. This is amongst the best in the industry. HLBN outperforms 84.62% of its industry peers.
HLBN's Profit Margin has improved in the last couple of years.
HLBN's Operating Margin of 16.58% is amongst the best of the industry. HLBN outperforms 92.31% of its industry peers.
HLBN's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 44.22%, HLBN is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
HLBN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.58%
PM (TTM) 11.07%
GM 44.22%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
HLBN.DE Yearly Profit, Operating, Gross MarginsHLBN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

HLBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
HLBN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HLBN has been reduced compared to 5 years ago.
HLBN has a better debt/assets ratio than last year.
HLBN.DE Yearly Shares OutstandingHLBN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
HLBN.DE Yearly Total Debt VS Total AssetsHLBN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 2.83 indicates that HLBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.83, HLBN is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
HLBN has a debt to FCF ratio of 3.45. This is a good value and a sign of high solvency as HLBN would need 3.45 years to pay back of all of its debts.
HLBN's Debt to FCF ratio of 3.45 is fine compared to the rest of the industry. HLBN outperforms 76.92% of its industry peers.
HLBN has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HLBN (0.44) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.45
Altman-Z 2.83
ROIC/WACC1.61
WACC4.63%
HLBN.DE Yearly LT Debt VS Equity VS FCFHLBN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

HLBN has a Current Ratio of 1.25. This is a normal value and indicates that HLBN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.25, HLBN is doing worse than 84.62% of the companies in the same industry.
A Quick Ratio of 0.93 indicates that HLBN may have some problems paying its short term obligations.
With a Quick ratio value of 0.93, HLBN is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.93
HLBN.DE Yearly Current Assets VS Current LiabilitesHLBN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

The earnings per share for HLBN have decreased by -2.24% in the last year.
The Earnings Per Share has been growing slightly by 7.24% on average over the past years.
HLBN shows a decrease in Revenue. In the last year, the revenue decreased by -2.23%.
Measured over the past years, HLBN shows a decrease in Revenue. The Revenue has been decreasing by -0.24% on average per year.
EPS 1Y (TTM)-2.24%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%-3.15%
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-2.5%

3.2 Future

HLBN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.02% yearly.
HLBN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.78% yearly.
EPS Next Y10.1%
EPS Next 2Y7.51%
EPS Next 3Y8.35%
EPS Next 5Y6.02%
Revenue Next Year1.97%
Revenue Next 2Y3.05%
Revenue Next 3Y3.53%
Revenue Next 5Y3.78%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HLBN.DE Yearly Revenue VS EstimatesHLBN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
HLBN.DE Yearly EPS VS EstimatesHLBN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.86, HLBN is valued on the expensive side.
61.54% of the companies in the same industry are more expensive than HLBN, based on the Price/Earnings ratio.
HLBN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.34.
With a Price/Forward Earnings ratio of 14.43, HLBN is valued correctly.
HLBN's Price/Forward Earnings is on the same level as the industry average.
HLBN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 17.86
Fwd PE 14.43
HLBN.DE Price Earnings VS Forward Price EarningsHLBN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

HLBN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. HLBN is more expensive than 69.23% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLBN indicates a somewhat cheap valuation: HLBN is cheaper than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.46
EV/EBITDA 9.79
HLBN.DE Per share dataHLBN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
HLBN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.77
PEG (5Y)2.47
EPS Next 2Y7.51%
EPS Next 3Y8.35%

4

5. Dividend

5.1 Amount

HLBN has a Yearly Dividend Yield of 3.25%.
Compared to an average industry Dividend Yield of 3.44, HLBN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, HLBN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.25%

5.2 History

On average, the dividend of HLBN grows each year by 39.59%, which is quite nice.
Dividend Growth(5Y)39.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

53.73% of the earnings are spent on dividend by HLBN. This is a bit on the high side, but may be sustainable.
HLBN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP53.73%
EPS Next 2Y7.51%
EPS Next 3Y8.35%
HLBN.DE Yearly Income VS Free CF VS DividendHLBN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
HLBN.DE Dividend Payout.HLBN.DE Dividend Payout, showing the Payout Ratio.HLBN.DE Dividend Payout.PayoutRetained Earnings

HOLCIM LTD

FRA:HLBN (6/18/2025, 7:00:00 PM)

99.28

-0.87 (-0.87%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)04-25 2025-04-25
Earnings (Next)07-31 2025-07-31
Inst Owners35.55%
Inst Owner ChangeN/A
Ins Owners6.57%
Ins Owner ChangeN/A
Market Cap57.50B
Analysts71.43
Price Target105.4 (6.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.25%
Yearly Dividend3.01
Dividend Growth(5Y)39.59%
DP53.73%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.48%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.86
Fwd PE 14.43
P/S 2.05
P/FCF 13.46
P/OCF 9.54
P/B 1.98
P/tB 5.27
EV/EBITDA 9.79
EPS(TTM)5.56
EY5.6%
EPS(NY)6.88
Fwd EY6.93%
FCF(TTM)7.38
FCFY7.43%
OCF(TTM)10.41
OCFY10.48%
SpS48.49
BVpS50.02
TBVpS18.85
PEG (NY)1.77
PEG (5Y)2.47
Profitability
Industry RankSector Rank
ROA 5.38%
ROE 10.73%
ROCE 9.83%
ROIC 7.46%
ROICexc 8.47%
ROICexgc 14.95%
OM 16.58%
PM (TTM) 11.07%
GM 44.22%
FCFM 15.21%
ROA(3y)5.62%
ROA(5y)4.77%
ROE(3y)11.3%
ROE(5y)9.72%
ROIC(3y)6.46%
ROIC(5y)6.04%
ROICexc(3y)7.58%
ROICexc(5y)7.02%
ROICexgc(3y)13.04%
ROICexgc(5y)11.56%
ROCE(3y)8.52%
ROCE(5y)7.98%
ROICexcg growth 3Y12.63%
ROICexcg growth 5Y13.6%
ROICexc growth 3Y7.66%
ROICexc growth 5Y8.99%
OM growth 3Y4.25%
OM growth 5Y6.16%
PM growth 3Y9.2%
PM growth 5Y5.79%
GM growth 3Y0.94%
GM growth 5Y0.93%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.45
Debt/EBITDA 1.88
Cap/Depr 81.89%
Cap/Sales 6.25%
Interest Coverage 8.17
Cash Conversion 88.64%
Profit Quality 137.47%
Current Ratio 1.25
Quick Ratio 0.93
Altman-Z 2.83
F-Score6
WACC4.63%
ROIC/WACC1.61
Cap/Depr(3y)149.39%
Cap/Depr(5y)143.09%
Cap/Sales(3y)11.07%
Cap/Sales(5y)11.4%
Profit Quality(3y)72.22%
Profit Quality(5y)84.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.24%
EPS 3Y11.85%
EPS 5Y7.24%
EPS Q2Q%-3.15%
EPS Next Y10.1%
EPS Next 2Y7.51%
EPS Next 3Y8.35%
EPS Next 5Y6.02%
Revenue 1Y (TTM)-2.23%
Revenue growth 3Y-0.53%
Revenue growth 5Y-0.24%
Sales Q2Q%-2.5%
Revenue Next Year1.97%
Revenue Next 2Y3.05%
Revenue Next 3Y3.53%
Revenue Next 5Y3.78%
EBIT growth 1Y2.46%
EBIT growth 3Y3.69%
EBIT growth 5Y5.91%
EBIT Next Year43.61%
EBIT Next 3Y16.89%
EBIT Next 5Y11.52%
FCF growth 1Y101.86%
FCF growth 3Y238.03%
FCF growth 5Y4.99%
OCF growth 1Y3.6%
OCF growth 3Y3.95%
OCF growth 5Y3.27%